Forward Citations = 0

Loading Chart...

5 inventors (with patents filed for the assignee):

Wen Kang Xu (3 out of 8 patents)

Shanzhong Jian (3 out of 5 patents)

Jintao Zhang (3 out of 7 patents)

4. Qun Li (2 out of 6 patents)

5. Ao Qiong Li (1 out of 10 patents)

3 patents: Sort by Forward Citations

1. 11548868 - Heterocyclic compounds, compositions comprising heterocyclic compound, and methods of use thereof (2023-01-10),

2. 11242334 - Heterocyclic compounds as kinase inhibitors, compositions comprising the heterocyclic compound, and methods of use thereof (2022-02-08),

3. 10479791 - Heterocyclic compounds as ERK inhibitors (2019-11-19),

Company Badge

USPTO Data Jan 1 1976 - Oct 20 2026

3 Patents

#657 in Shanghai

#8,360 in China

Shanghai, China

Js Innopharm (Shanghai) Ltd.

Forward Citations = 0

5 inventors:

Wen Kang Xu (3 out of 8 patents)

Shanzhong Jian (3 out of 5 patents)

Jintao Zhang (3 out of 7 patents)

4. Qun Li (2 out of 6 patents)

5. Ao Qiong Li (1 out of 10 patents)

IDiyas Innovation Intelligence. (2026). Company Patent Portfolio: Js Innopharm (Shanghai) Ltd.. Retrieved from https://idiyas.com/company/js-innopharm-shanghai

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]